- Report
- April 2023
- 239 Pages
Global
From €3063EUR$3,185USD£2,627GBP
€4375EUR$4,550USD£3,753GBP
- Report
- June 2020
- 114 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- January 2019
- 97 Pages
Global
From €3846EUR$4,000USD£3,299GBP
- Report
- September 2022
- 120 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- January 2019
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- October 2019
- 108 Pages
Global
From €4279EUR$4,450USD£3,671GBP
- Report
- August 2018
- 115 Pages
Global
From €4519EUR$4,700USD£3,877GBP
- Report
- May 2023
- 113 Pages
Global
From €3500EUR$3,899USD£3,108GBP
The Structural Heart Device market is a subset of the Cardiovascular Devices market, which includes products used to diagnose and treat cardiovascular diseases. Structural Heart Devices are used to treat structural heart defects, such as atrial septal defects, patent foramen ovale, and mitral valve regurgitation. These devices are typically implanted in the heart and can include transcatheter aortic valve replacement (TAVR) devices, occluders, and annuloplasty rings.
Structural Heart Devices are used to improve patient outcomes and reduce the need for open-heart surgery. They are also used to reduce the risk of stroke and other complications associated with structural heart defects.
Some companies in the Structural Heart Device market include Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and St. Jude Medical. Show Less Read more
